Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
48.38
+0.56 (+1.17%)
Streaming Delayed Price
Updated: 2:33 PM EDT, Oct 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
509,133
Open
47.86
Bid (Size)
48.38 (9)
Ask (Size)
48.45 (9)
Prev. Close
47.82
Today's Range
47.20 - 48.54
52wk Range
37.55 - 91.10
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is CRISPR Therapeutics Stock a Buy?
October 13, 2024
The markets this biotech is looking to enter could be extremely lucrative.
Via
The Motley Fool
2 Biotech Stocks That Are Screaming Buys This Month
October 12, 2024
They won't remain southbound forever.
Via
The Motley Fool
Performance
YTD
-26.76%
-26.76%
1 Month
+1.34%
+1.34%
3 Month
-15.80%
-15.80%
6 Month
-17.61%
-17.61%
1 Year
+7.97%
+7.97%
More News
Read More
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now
October 05, 2024
Via
The Motley Fool
These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer
October 02, 2024
Via
The Motley Fool
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
September 26, 2024
Via
Investor's Business Daily
3 Dirt Cheap Stocks to Buy Right Now
September 21, 2024
Via
The Motley Fool
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
September 19, 2024
Via
The Motley Fool
1 Biotech Stock Down 62% to Buy and Hold
September 12, 2024
Via
The Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
Via
The Motley Fool
Looking for Stock Bargains With Room to Run? Try This.
September 11, 2024
Via
The Motley Fool
Down Nearly 50% From Its 52-Week High, Is CRISPR Therapeutics a Steal of a Deal?
September 05, 2024
Via
The Motley Fool
3 Monster Biotech Stocks to Buy Before 2025
September 02, 2024
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
August 26, 2024
Via
The Motley Fool
Got the Market Sell-Off Blues? Do These 3 Things Right Now
August 11, 2024
Via
The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
August 08, 2024
Via
Benzinga
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
Via
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in August 2024
August 07, 2024
Via
InvestorPlace
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Via
The Motley Fool
CRSP Stock Earnings: CRISPR Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 05, 2024
Via
InvestorPlace
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
August 05, 2024
Via
The Motley Fool
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
August 04, 2024
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
Via
The Motley Fool
10 Best Small and Mid-Cap Stocks to Consider Buying in August
August 01, 2024
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 31, 2024
Via
The Motley Fool
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024
July 29, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.